Since our founding in 2007, Akebia (Nasdaq: AKBA) has been focused on achieving better outcomes for people with kidney disease. We are a leader in the renal community – a fully integrated biopharmaceutical company with capabilities ranging from research through commercialization.
We have a portfolio focused on addressing significant unmet needs for people living with kidney disease.
RESEARCH & DEVELOPMENT
Events & Presentations
November 29, 2022 at 2:30 PM EST
November 3, 2022 at 4:30 PM EDT
August 4, 2022 at 4:30 PM EDT